Research Topics
| Pierfrancesco AgostoniSummaryAffiliation: University of Verona Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Acute myocardial infarction probably caused by paradoxical embolus in a pregnant womanP Agostoni
Institute of Cardiology, Ospedale Civile Maggiore, University of Verona, Verona, Italy
Heart 90:e12. 2004..Pregnancy and factor V Leiden carriership are associated with increased risk of venous thromboembolism and the association between PFO and atrial septal aneurysm is a strong risk factor for systemic embolisation...
Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trialsPierfrancesco Agostoni
Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Verona, Italy
J Am Coll Cardiol 44:349-56. 2004..We sought to compare, through a meta-analytic process, the transradial and transfemoral approaches for coronary procedures in terms of clinical and procedural outcomes...- Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trialsPierfrancesco Agostoni
Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Piazzale Stefani 1, 37126 Verona, Italy
Eur Heart J 26:881-9. 2005..To compare, by meta-analytical techniques, the clinical impact of bare-metal stenting vs. balloon angioplasty for the treatment of lesions in small coronary arteries... - Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary interventionMarzia Lotrionte
Institute of Cardiology, Catholic University, Rome, Italy
Am J Cardiol 100:1199-206. 2007..In conclusion, a high clopidogrel loading dose (>300 mg) significantly reduces early ischemic events in patients scheduled for percutaneous coronary intervention... - Enhanced plasma levels of oxidized low-density lipoprotein increase circulating nuclear factor-kappa B activation in patients with unstable anginaLuciano Cominacini
Department of Biomedical and Surgical Sciences, Section of Internal Medicine, University of Verona, Verona, Italy
J Am Coll Cardiol 46:799-806. 2005.... - Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromesLuca Testa
Institute of Cardiology, John Radcliffe Hospital, Oxford, United Kingdom, and Division of Cardiology, University of Turin, Italy
Am J Cardiol 99:1637-42. 2007..Allocating 100 patients to A+W (at international normalized ratio 2 to 3) with respect to A+C could prevent 17 thromboembolic strokes while causing 3 major bleeds... 
Ischemia induced by transesophageal atrial pacing stress echocardiography predicts long-term mortalityMaurizio Anselmi
Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Verona, Italy
Cardiology 111:111-8. 2008..It was the aim of this study to investigate the long-term value of transesophageal atrial pacing in predicting death in patients with known or suspected coronary artery disease...- Safety of percutaneous left heart catheterization directly performed by cardiology fellows: a cohort analysisPierfrancesco Agostoni
University of Verona, Italy
J Invasive Cardiol 18:248-52. 2006..Of course, the presence and watchful supervision of an attending physician is still essential to ensure both patient safety and optimal training... - Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaquesMaurizio Anselmi
Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Verona, Italy
Atherosclerosis 185:114-20. 2006.... - Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregressionGiuseppe G L Biondi-Zoccai
Institute of Cardiology, Catholic University, Rome, Italy
Am Heart J 149:504-11. 2005..We performed a metaregression to explore the impact of intracoronary stenting and aggressive antiplatelet treatment on the risk/benefit ratio of an early invasive approach... - Long-term effect of chronic oral anticoagulation: focus on coronary artery diseaseMarzia Lotrionte
Institute of Cardiology, Catholic University, Rome, Italy
Future Cardiol 5:259-71. 2009..This review provides a succinct and updated appraisal of the long-term effects of chronic oral anticoagulation in the setting of coronary artery disease... - Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? A meta-analysisGiuseppe G L Biondi-Zoccai
Institute of Cardiology, Catholic University, Largo A Gemelli 8, 00168 Rome, Italy
Resuscitation 59:221-4. 2003..Evidence in humans is still limited and confidence intervals estimates too wide to reliably confirm or disprove results obtained in experimental animal settings... - Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesionsJohn Cosgrave
EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
Am J Cardiol 96:1663-8. 2005..Overall, the 2 available stent platforms had similar performance characteristics... - Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantationGiuseppe G L Biondi-Zoccai
Interventional Cardiology Unit, St Raffaele Hospital, Milan, Italy
Eur Heart J 27:540-6. 2006.... - Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGMarco Valgimigli
Cardiology, University of Ferrara, Ferrara, Italy
Am Heart J 154:39-45. 2007..Similarly, whether tirofiban administered at high-bolus dose (HBD) followed by standard infusion is a valuable alternative to abciximab in the setting of ST-segment elevation myocardial infarction remains uncertain... - Is late luminal loss an accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries?Pierfrancesco Agostoni
Antwerp Cardiovascular Institute Middleheim, AZ Middelheim, Antwerp, Belgium
Am J Cardiol 97:603-5. 2006.... - Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC TrialPaul Vermeersch
Antwerp Cardiovascular Institute Middelheim, AZ Middelheim, Antwerp, Belgium
J Am Coll Cardiol 50:261-7. 2007..We sought to provide long-term follow-up data of sirolimus-eluting stents (SES) versus bare-metal stents (BMS) in saphenous vein grafts (SVG) from the RRISC (Reduction of Restenosis In Saphenous vein grafts with Cypher) trial... - Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regressionGiuseppe G L Biondi-Zoccai
Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
Am Heart J 153:587-93. 2007..We performed a systematic review and meta-regression of randomized clinical trials comparing clopidogrel versus ticlopidine, focusing on clopidogrel front-loading... - Letter of comment on "Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial" (Am Tom Vydt
Am Heart J 153:e25; author reply e27. 2007 - Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stentsPierfrancesco Agostoni
San Raffaele Hospital, Milan, Italy
Am J Cardiol 99:593-8. 2007..Thus, late loss may not be a reliable marker of the true efficacy of these devices due to its complex and nongaussian distribution... - Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesionsLei Ge
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China
Chin Med J (Engl) 120:545-51. 2007..The aim of the present report was to evaluate the long-term outcome following implantation of DES in unprotected LM bifurcation lesions... - Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratoryMarco Valgimigli
Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
J Cardiovasc Med (Hagerstown) 8:221-9. 2007..Thus, a combination of several modalities will be important in the future to ensure a high sensitivity and specificity in detecting vulnerable plaques... - Recurrent angina after coronary revascularization: a clinical challengeAntonio Abbate
Division of Cardiology, West Hospital, Virginia Commonwealth University VCU Pauley Heart Center, 1200 E, Marshall Street, PO Box 980036, Richmond, VA 23298 0036, USA
Eur Heart J 28:1057-65. 2007..This review attempts to summarize the most common causes of recurrent chest pain after coronary revascularization, to analyse the possible diagnostic approaches, and to discuss the potential treatment modalities... - Successful percutaneous treatment of an intraprocedural left main stent thrombosis with the support of an automatic mechanical chest compression devicePierfrancesco Agostoni
Int J Cardiol 124:e19-21. 2008 - Bifurcation stenting with a dedicated biolimus-eluting stent: X-ray visual enhancement of the final angiographic result with "StentBoost Subtract"Pierfrancesco Agostoni
Antwerp Cardiovascular Institute Middelheim, AZ Middelheim, Antwerp, Belgium
Catheter Cardiovasc Interv 70:233-6. 2007.... - Treatment of restenosis with a paclitaxel-coated balloon catheterPierfrancesco Agostoni
N Engl J Med 356:1071-2; author reply 1072-3. 2007 - Engineering aspects of stents design and their translation into clinical practiceGiuseppe Sangiorgi
Ospedale San Raffaele, Via Olgettina 64, 20132 Milan, Italy
Ann Ist Super Sanita 43:89-100. 2007.... - Re: early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM trialLuca Testa
Eur Heart J 28:1782-3; author reply 1783. 2007 - Bare-metal versus drug-eluting coronary stentsPierfrancesco Agostoni
N Engl J Med 358:2516-7; author reply 2517-8. 2008 - Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trialMarco Valgimigli
Cardiovascular Institute, University of Ferrara, Ferrara, Italy
JAMA 299:1788-99. 2008..Similarly, the use of drug-eluting stents in this patient population is currently discouraged because of conflicting results on efficacy reported in randomized trials and safety concerns reported by registries... - Revisiting the role of percutaneous revascularization versus medical therapy for later infarct-related artery occlusion (letter of comment on Ioannidis and Katritsis. Am Heart J. 2007;154:1065-71)Darryn Appleton
Am Heart J 155:e41; author reply e43. 2008 - Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trialsAntonio Abbate
Virginia Commonwealth University VCU Pauley Heart Center, Richmond, Virginia 23298, USA
J Am Coll Cardiol 51:956-64. 2008.... - Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidancePierfrancesco Agostoni
Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
Am J Cardiol 95:644-7. 2005..The use of intravascular ultrasound, used in 41% of the procedures, was not associated with additional clinical benefit with respect to angiographic-assisted stent deployment... - Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET)Pierfrancesco Agostoni
Eur Heart J 28:1912-3; author reply 1913. 2007 - Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial)Pierfrancesco Agostoni
Antwerp Cardiovascular Institute Middelheim, AZ Middelheim, Antwerp, Belgium
Am J Cardiol 100:52-8. 2007..The neointimal response to overlapping SES layers seems higher than to a single SES layer... - Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practiceJohn Cosgrave
EMO Centro Cuore Columbus, Milan, Italy
J Am Coll Cardiol 49:2320-8. 2007..This study was designed to compare the outcomes of paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) in a contemporaneous cohort of real-world patients... - Clinical implications of the PROTECT-TIMI-30 trialMarco Valgimigli
J Am Coll Cardiol 49:729-30; author reply 730-1. 2007 - Keeping a high standard in quantitative analyses, meta-analyses, and systematic reviewsGiuseppe G L Biondi-Zoccai
Eur Heart J 28:516-7; author reply 517-8. 2007 - Meta-analysis of the studies assessing temporal changes in coronary plaque volume using intravascular ultrasoundGaston A Rodriguez-Granillo
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Am J Cardiol 99:5-10. 2007..13 mm(3), 95% confidence interval -4.42 to 4.68, p = 0.96). In conclusion, statin therapy, particularly when achieving the target LDL level, appears to promote a significant regression of coronary plaque volume as measured by IVUS... - Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patientsGiuseppe G L Biondi-Zoccai
Int J Cardiol 114:104-5. 2007..66 [0.52-0.84], p=0.0008 for target lesion revascularization). Indeed, such combination of direct and indirect comparisons should also be envisaged to soundly and timely appraise the next generation of drug-eluting stents... - Letter regarding article by Mauri et al, "Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison"Pierfrancesco Agostoni
Circulation 112:e358; author reply e358. 2005 - Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents?Paul Vermeersch
The Department of Cardiology, AZ Middelheim, Antwerp, Belgium
J Interv Cardiol 18:467-73. 2005..These devices are potentially the principal promise for the long-term successful sealing of vein graft disease; however, clear and definitive data coming from controlled trials are requested... - In-vivo, cardiac-cycle related intimal displacement of coronary plaques assessed by 3-D ECG-gated intravascular ultrasound: exploring its correlate with tissue deformability identified by palpographyGaston A Rodriguez-Granillo
Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
Int J Cardiovasc Imaging 22:147-52. 2006..ECG-gated image acquisition of intravascular ultrasound (IVUS) has been shown to provide more accurate measurements at different phases of the cardiac cycle... - Antioxidant vitamins and coronary diseaseGiuseppe G L Biondi-Zoccai
N Engl J Med 346:1092-3. 2002 - ST-segment elevation acute myocardial infarction: reperfusion at any cost?Antonio Abbate
Eur Heart J 26:1813-5. 2005 - Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent eraGiuseppe G L Biondi-Zoccai
St. Raffaele Hospital, Milan, Italy
Am J Cardiol 95:1466-8. 2005..Such results may provide useful information to guide prevention of this complication... - Critical role of bare-metal stent controls in trials of drug-eluting stentsGiuseppe G L Biondi-Zoccai
Eur Heart J 26:1686-7; author reply 1687. 2005 - Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trialsGiuseppe G L Biondi-Zoccai
Invasive Cardiology, San Raffaele Hospital, and EMO Centro Cuore Columbus, Milan, Italy
Int J Cardiol 100:119-23. 2005..Drug-eluting stents (DES) have been recently investigated, with favorable data for many devices, but comparative data are lacking. We thus performed an adjusted indirect comparison metaanalysis of DES... - Coronary stenting versus balloon angioplasty in small vesselsPierfrancesco Agostoni
J Am Coll Cardiol 45:323-4; author reply 324-5. 2005 - Drawbacks of nonrandomized trials in acute coronary syndromesGiuseppe G L Biondi-Zoccai
Am J Cardiol 97:151. 2006 - Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case studyGiuseppe G L Biondi-Zoccai
Hemodynamics and Cardiovascular Radiology Service, Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Italy
BMJ 332:202-9. 2006..To appraise multiple systematic reviews on the same clinical topic, focusing on predictors and correlates of quality of reporting of meta-analysis (QUOROM) scores... - Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: insights from a systematic overview of randomized trials in light of the drug-eluting stent eraPierfrancesco Agostoni
S Raffaele Hospital, Vita e Salute University, Milan, Italy
Am Heart J 151:682-9. 2006.... - Acute and mid-term local vascular effects of compliant balloon inflation (GuardWire system) on saphenous vein bypass grafts: an angiographic analysisPierfrancesco Agostoni
Antwerp Cardiovascular Institute Middelheim, AZ Middelheim, Lindendreef 1, 2020 Antwerp, Belgium
Int J Cardiol 120:227-31. 2007..We thus evaluated the angiographic outcome of the vein graft segment where the compliant balloon of the GuardWire distal protection device was inflated during percutaneous interventions of diseased vein grafts... - Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC TrialPaul Vermeersch
Antwerp Cardiovascular Institute Middelheim, AZ Middelheim, Antwerp, Belgium
J Am Coll Cardiol 48:2423-31. 2006..We sought to compare, in a randomized fashion, sirolimus-eluting stents (SES) versus bare-metal stents (BMS) in saphenous vein grafts (SVGs)... - Mastering the antegrade femoral artery access in patients with symptomatic lower limb ischemia: learning curve, complications, and technical tips and tricksGiuseppe G L Biondi-Zoccai
Hemodynamics and Cardiovascular Interventions Service, Abano Terme Hospital, Abano Terme, Italy
Catheter Cardiovasc Interv 68:835-42. 2006..We appraised learning curve, complications, and technical aspects inherent in the adoption of antegrade approach... - Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysisMichele Hamon
Department of Radiology of the University Hospital of Caen, Caen, Normandy, France
J Am Coll Cardiol 48:1896-910. 2006..This study was designed to define the current role of multislice spiral computed tomography (MSCT) for the diagnosis of coronary artery disease (CAD) using a meta-analytic process... - A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery diseaseGiuseppe G L Biondi-Zoccai
Interventional Cardiology, Division of Cardiology, University of Turin, Corso Bramante 88 90, 10126 Turin, Italy
Eur Heart J 27:2667-74. 2006..We thus undertook a systematic review to appraise the hazards inherent to aspirin withdrawal or non-compliance in subjects at risk for or with CAD... - Dissimilar relevance given to diseases by medical literature, and the potential to create biases in the clinical decision-making process: the case of late stent thrombosisPierfrancesco Agostoni
Int J Cardiol 114:E38-9. 2007.... - Macroscopic assessment of porcine coronary vessel wall trauma after percutaneous cardiac catheterization and interventionPierfrancesco Agostoni
Int J Cardiol 113:E87-8. 2006.... - Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Giuseppe G L Biondi Zoccai
Mediolanum Cardio Research, Milan, Italy
Int J Cardiol 117:349-54. 2007..Indeed, the TRUE Study, including as much as 115 ULM and 229 bifurcation interventions, should give important insights into the outcome of PES in such an unprecedented and challenging context... - The drug-eluting stent dilemma: comparing the effectiveness of Cypher versus TaxusGiuseppe G L Biondi-Zoccai
J Cardiovasc Med (Hagerstown) 7:2-4. 2006 - Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) StudyGiuseppe G L Biondi-Zoccai
Int J Cardiol 108:406-7. 2006..These findings thus support the overall safety and effectiveness of ticlopidine after DES implantation, and also confirm the increased risk of late thrombosis when premature withdrawal of thienopyridines occurs... - Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trialsGiuseppe G L Biondi-Zoccai
Istituto di Cardiologia Università Cattolica del Sacro Cuore Policlinico A Gemelli Largo A Gemelli, 8 00168 Roma
Ital Heart J 4:271-80. 2003..We thus undertook a systematic overview of the randomized trials comparing stenting vs CABG in coronary artery disease...